Opportunity Abounds for Celgene (CELG) in Multiple Segments - Cramer
Go back to Opportunity Abounds for Celgene (CELG) in Multiple Segments - Cramer| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 65.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.47 | 52 Week Low | $49.03 | |||
| Day High | $65.47 | P/E | 42.51 | |||
| Day Low | $65.47 | EPS | $1.54 | |||
| Volume | 1,095,603 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
